Studying skin cells to understand scleroderma
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This study uses skin samples from people with scleroderma, their relatives, and healthy volunteers to create stem cells in a lab. The goal is to learn more about the disease and find better ways to treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have a diagnosis of scleroderma for at least 12 months, or you are a first-degree relative (parent, sibling, or adult child) of someone with scleroderma.
- If you have scleroderma, your doctor has confirmed the type and severity.
- You do not have other serious illnesses like active cancer or blood disorders.
- You are not pregnant or breastfeeding, and you are not under legal guardianship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares skin samples from people with scleroderma and healthy volunteers to understand what goes wrong in the skin. It may help researchers find new treatment targets.
This trial tests whether stem cells from umbilical cord blood can help treat systemic sclerosis (scleroderma). The goal is to see if this treatment can improve skin thickening and overall symptoms for people who haven't had success with standard therapies.
This study looks at how a new drug affects skin scarring (fibrosis) in people with systemic sclerosis (SSc), a rare autoimmune disease. It aims to understand if this drug can help reduce the skin thickening and immune changes caused by SSc.
This trial collects clinical and lab information (like blood and medical history) from people with rare autoimmune diseases, especially when symptoms are unusual. It aims to better understand what causes these illnesses and how newer treatments may help.
This study looks at changes in gut bacteria over time in people with systemic sclerosis (a connective tissue disease). It also compares them with healthy adults to understand what gut bacteria patterns may be linked to this condition.
This study collects skin samples and medical information from people with skin conditions caused by their immune system. It helps researchers better understand these diseases and develop new treatments.
Hear when a new Systemic Sclerosis (SSc) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.